360 related articles for article (PubMed ID: 18695637)
21. Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.
Lobato NS; Filgueira FP; Prakash R; Giachini FR; Ergul A; Carvalho MH; Webb RC; Tostes RC; Fortes ZB
PLoS One; 2013; 8(5):e63449. PubMed ID: 23667622
[TBL] [Abstract][Full Text] [Related]
22. Relationship between seminal plasma levels of anandamide congeners palmitoylethanolamide and oleoylethanolamide and semen quality.
Amoako AA; Marczylo TH; Elson J; Taylor AH; Willets JM; Konje JC
Fertil Steril; 2014 Nov; 102(5):1260-7. PubMed ID: 25212838
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
24. Increases in vanilloid TRPV1 receptor protein and CGRP content during endotoxemia in rats.
Orliac ML; Peroni RN; Abramoff T; Neuman I; Podesta EJ; Adler-Graschinsky E
Eur J Pharmacol; 2007 Jul; 566(1-3):145-52. PubMed ID: 17482593
[TBL] [Abstract][Full Text] [Related]
25. Effects of hypertension on vasorelaxation to endocannabinoids in vitro.
Wheal AJ; Randall MD
Eur J Pharmacol; 2009 Jan; 603(1-3):79-85. PubMed ID: 19100733
[TBL] [Abstract][Full Text] [Related]
26. 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism.
Smart D; Jonsson KO; Vandevoorde S; Lambert DM; Fowler CJ
Br J Pharmacol; 2002 Jun; 136(3):452-8. PubMed ID: 12023948
[TBL] [Abstract][Full Text] [Related]
27. Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy.
Silva M; Martins D; Charrua A; Piscitelli F; Tavares I; Morgado C; Di Marzo V
Neuropharmacology; 2016 Aug; 107():49-57. PubMed ID: 26965218
[TBL] [Abstract][Full Text] [Related]
28. Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed.
Mendizábal VE; Orliac ML; Adler-Graschinsky E
Eur J Pharmacol; 2001 Sep; 427(3):251-62. PubMed ID: 11567656
[TBL] [Abstract][Full Text] [Related]
29. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors.
De Petrocellis L; Davis JB; Di Marzo V
FEBS Lett; 2001 Oct; 506(3):253-6. PubMed ID: 11602256
[TBL] [Abstract][Full Text] [Related]
30. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1998 Oct; 125(3):533-41. PubMed ID: 9806337
[TBL] [Abstract][Full Text] [Related]
31. Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells.
Matias I; Gonthier MP; Petrosino S; Docimo L; Capasso R; Hoareau L; Monteleone P; Roche R; Izzo AA; Di Marzo V
Br J Pharmacol; 2007 Nov; 152(5):676-90. PubMed ID: 17704823
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
33. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.
Sudhahar V; Shaw S; Imig JD
Eur J Pharmacol; 2009 Apr; 607(1-3):143-50. PubMed ID: 19326479
[TBL] [Abstract][Full Text] [Related]
35. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
36. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder.
Saitoh C; Kitada C; Uchida W; Chancellor MB; de Groat WC; Yoshimura N
Eur J Pharmacol; 2007 Sep; 570(1-3):182-7. PubMed ID: 17586490
[TBL] [Abstract][Full Text] [Related]
37. Anandamide induces endothelium-dependent vasoconstriction and CGRPergic nerve-mediated vasodilatation in the rat mesenteric vascular bed.
Tamaki C; Nawa H; Takatori S; Oda S; Sendo T; Zamami Y; Kawasaki H
J Pharmacol Sci; 2012; 118(4):496-505. PubMed ID: 22510966
[TBL] [Abstract][Full Text] [Related]
38. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα.
Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929
[TBL] [Abstract][Full Text] [Related]
39. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
Smaga I; Bystrowska B; Gawliński D; Pomierny B; Stankowicz P; Filip M
Neurotox Res; 2014 Aug; 26(2):190-206. PubMed ID: 24652522
[TBL] [Abstract][Full Text] [Related]
40. Activation of TRPV1 by the satiety factor oleoylethanolamide.
Ahern GP
J Biol Chem; 2003 Aug; 278(33):30429-34. PubMed ID: 12761211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
